Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
Full metadata record
|dc.identifier.citation||International Journal of Cancer, 2013; 133(10):2263-2276||en|
|dc.description.abstract||As it was first characterized in 1997, the ADAMTS (A Disintegrin and Metalloprotease with ThromboSpondin motifs) metalloprotease family has been associated with many physiological and pathological conditions. Of the 19 proteases belonging to this family, considerable attention has been devoted to the role of its first member ADAMTS1 in cancer. Elevated ADAMTS1 promotes pro-tumorigenic changes such as increased tumor cell proliferation, inhibited apoptosis and altered vascularization. Importantly, it facilitates significant peritumoral remodeling of the extracellular matrix environment to promote tumor progression and metastasis. However, discrepancy exists, as several studies also depict ADAMTS1 as a tumor suppressor. This article reviews the current understanding of ADAMTS1 regulation and the consequence of its dysregulation in primary cancer and ADAMTS1-mediated pathways of cancer progression and metastasis.||en|
|dc.description.statementofresponsibility||Izza de Arao Tan, Carmela Ricciardelli and Darryl L. Russell||en|
|dc.rights||Copyright © 2013 UICC||en|
|dc.subject||ADAMTS1; cancer; metastasis; pathways; metalloproteinase||en|
|dc.title||The metalloproteinase ADAMTS1: A comprehensive review of its role in tumorigenic and metastatic pathways||en|
|pubs.library.collection||Obstetrics and Gynaecology publications||en|
|dc.identifier.orcid||Ricciardelli, C. [0000-0001-7415-1854]||en|
|dc.identifier.orcid||Russell, D. [0000-0002-4930-7658]||en|
|Appears in Collections:||Obstetrics and Gynaecology publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.